Research Peptide Vials
SS-31
SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide developed at Cornell University. Research has focused on its ability to bind cardiolipin on the inner mitochondrial membrane, stabilizing mitochondrial structure and improving bioenergetics in aged or damaged tissues.
Product Name: | Elamipretide |
Synonyms: | D-Arginyl-2,6-diMethyl-L-tyrosyl-L-lysyl-L-phenylalaninaMide;Elamipretide;Centanafadine;L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-;Elamipretide (TFA salt);SS-31;MTP-131;BENDAVIA;Bendavia);Elamipretide (SS-31) |
CAS: | 736992-21-5 |
MF: | C32H49N9O5 |
MW: | 639.79 |
EINECS: | 205-858-1 |
Elamipretide, also known as MTP 131, is a mitochondria-targeted peptide antioxidant. Elamipretide decreases inflammation and protect against a variety of neurological illnesses. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.